Is Satsuma Pharmaceuticals Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 3 Wall Street analysts covering (NASDAQ: STSA) stock is to Hold STSA stock.
Out of 3 analysts, 0 (0%) are recommending STSA as a Strong Buy, 1 (33.33%) are recommending STSA as a Buy, 2 (66.67%) are recommending STSA as a Hold, 0 (0%) are recommending STSA as a Sell, and 0 (0%) are recommending STSA as a Strong Sell.
According to 3 Wall Street analysts that have issued a 1 year STSA price target, the average STSA price target is $2.00, with the highest STSA stock price forecast at $3.00 and the lowest STSA stock price forecast at $1.00.
On average, Wall Street analysts predict that Satsuma Pharmaceuticals's share price could reach $2.00 by Nov 15, 2023. The average Satsuma Pharmaceuticals stock price prediction forecasts a potential upside of 135.02% from the current STSA share price of $0.85.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.